Antigen targets of type 1 diabetes autoimmunity

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 4, 2012, Pages

  Roep, Bart O ^a   Peakman, Mark ^b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; EPITOPE; GLUTAMATE DECARBOXYLASE 65; HLA ANTIGEN; INSULINOMA ANTIGEN 2; ISLET CELL AUTOANTIBODY; ISLET SPECIFIC GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNI TRELATED PROTEIN; PREPROINSULIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CELL SELECTION; GENETIC POLYMORPHISM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; POSTTRANSCRIPTIONAL MODIFICATION; PROTEIN INDUCTION, SYNTHESIS AND MODIFICATION; PROTEIN PROCESSING; THYMUS; ANTIGEN PRESENTATION; BLOOD; GENETICS; IMMUNOLOGY; REVIEW;

ANTIGEN PRESENTATION; AUTOANTIGENS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; EPITOPES; HUMANS; IMMUNOTHERAPY; INSULIN-SECRETING CELLS; SELF TOLERANCE;

EID: 84862302663     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007781     Document Type: Article

References (81)

1. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. 2005. Natural history of type 1 diabetes. Diabetes 54 (Suppl 2): S25-S31.
2. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von BoehmerH, Bronson R, Dierich A, Benoist C, et al. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401.
3. Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, de Vries RR, HuttonJC. 1996. Imogen 38: A novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest 97: 551-561.
4. Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, et al. 2000. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191: 603-612.
5. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, PeakmanM. 2004. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113: 451-463.
6. Atkinson MA, Maclaren NK. 1993. Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92: 1608-1616.
7. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, ErlanderMG, Tobin AJ, Maclaren NK. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459.
8. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156.
9. Bottazzo GF, Florin-Christensen A, Doniach D. 1974. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279-1283.
10. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353-360.
11. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP. 1996. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol 157: 5668-5674.
12. Chentoufi AA, Polychronakos C. 2002. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: The mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51: 1383-1390.
13. Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC, Gottlieb PA, Davidson HW. 2011. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 186: 6056-6063.
14. + T cells. Diabetes 60: 2325-2330.
15. Diez J, Park Y, Zeller M, Brown D, Garza D, Ricordi C, Hutton J, Eisenbarth GS, Pugliese A. 2001. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 50: 895-900.
16. Di Lorenzo TP, Peakman M, Roep BO. 2007. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148: 1-16.
17. Dogra RS, Vaidyanathan P, Prabakar KR, Marshall KE, Hutton JC, Pugliese A. 2006. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia 49: 953-957.
18. Durinovic-Bello I, Hummel M, Ziegler AG. 1996. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45: 795-800.
19. Eizirik DL, Colli ML, Ortis F. 2009. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219-226.
20. Faideau B, Briand JP, Lotton C, Tardivel I, Halbout P, Jami J, Elliott JF, Krief P, Muller S, Boitard C, et al. 2004. Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice. J Immunol 172: 25-33.
21. + T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 206: 1525-1534.
22. Han B, Serra P, Amrani A, Yamanouchi J, Marée AF, Edelstein-Keshet L, Santamaria P. 2005. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: High efficiency of a low-affinity peptide. Nat Med 11: 645-652.
23. Harrison LC. 1992. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 13: 348-352.
24. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B. 1989. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci 86: 8000-8004.
25. Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK, ChristieMR, Roep BO. 2000. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49: 356-366.
26. Howson JM, Stevens H, Smyth DJ, Walker NM, Chandler KA, Bingley PJ, Todd JA. 2011. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 60: 2635-2644.
27. Karlsen AE, Hagopian WA, Petersen JS, Boel E, Dyrberg T, Grubin CE, MichelsenBK, Madsen OD, Lernmark A. 1992. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64, 000-M(r) autoantibodies. Diabetes 41: 1355-1359.
28. Kash SF, Condie BG, Baekkeskov S. 1999. Glutamate decarboxylase and GABA in pancreatic islets: Lessons from knock-out mice. Horm Metab Res 31: 340-344.
29. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72.
30. Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC. 1996. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2. Diabetes 45: 1344-1349.
31. Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, et al. 2008. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 359: 1909-1920.
32. + T-cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56: 613-621.
33. Mannering SI, Harrison LC, Williamson NA, Morris JS, Thearle DJ, Jensen KP, Kay TW, Rossjohn J, Falk BA, Nepom GT, et al. 2005. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202: 1191-1197.
34. Martin S, Kardorf J, Schulte B, Lampeter EF, Gries FA, Melchers I, Wagner R, Bertrams J, Roep BO, Pfützner A. 1995. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia 38: 351-355.
35. Mathis D, Benoist C. 2009. Aire. Annu Rev Immunol 27: 287-312.
36. Matthews JB, Staeva TP, Bernstein PL, Peakman M, von Herrath M. 2010. Developing combination immunotherapies for type 1 diabetes: Recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin Exp Immunol 160: 176-184.
37. Miyazaki I, Gaedigk R, Hui MF, Cheung RK, Morkowski J, Rajotte RV, DoschHM. 1994. Cloning of human and rat p69 cDNA, a candidate autoimmune target in type 1 diabetes. Biochim Biophys Acta 1227: 101-104.
38. Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D, Devendra D, Beilke J, Gianani R, Gill RG, et al. 2003. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci 100: 10376-10381.
39. Naik RG, Beckers C, Wentwoord R, Frenken A, Duinkerken G, Brooks-Worrell B, Schloot NC, Palmer JP, Roep BO. 2004. Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus. J Autoimmun 23: 55-61.
40. Neophytou PI, Roep BO, Arden SD, Muir EM, Duinkerken G, Kallan A, de VriesRR, Hutton JC. 1996. T-cell epitope analysis using subtracted expression libraries (TEASEL): Application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient. Proc Natl Acad Sci 93: 2014-2018.
41. Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C. 2006. Recognition of HLA class I-restricted β-cell epitopes in type 1 diabetes. Diabetes 55: 3068-3074.
42. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F. 1995. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181: 1923-1927.
43. Payton MA, Hawkes CJ, Christie MR. 1995. Relationship of the 37, 000-and 40, 000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96: 1506-1511.
44. Peakman M, von Herrath M. 2010. Antigen-specific immunotherapy for type 1 diabetes: Maximizing the potential. Diabetes 59: 2087-2093.
45. Peakman M, Stevens EJ, Lohmann T, Narendran P, Dromey J, Alexander A, Tomlinson AJ, Trucco M, Gorga JC, Chicz RM. 1999. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 104: 1449-1457.
46. Peakman M, Tree TI, Endl J, van Endert P, Atkinson MA, Roep BO. 2001. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: Report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-Cell Assays in Type 1 Diabetes. Diabetes 50: 1749-1754.
47. Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO. 2005. Autoreactive CD8 T cells associated with β-cell destruction in type 1 diabetes. Proc Natl Acad Sci 102: 18425-18430.
48. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, Stevens H, Jackson L, Simmonds MJ, et al. Type 1 Diabetes Genetics Consortium, 2011. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 7: e1002216.
49. Pugliese A, Zeller M, Fernandez A Jr., Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15: 293-297.
50. Roep BO, Arden SD, De Vries RR, Hutton JC. 1990. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345: 632-634.
51. Roep BO, Kallan AA, Hazenbos WL, Bruining GJ, Bailyes EM, Arden SD, HuttonJC, de Vries RR. 1991. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337: 1439-1441.
52. Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, Martin S. 1996. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 26: 1285-1289.
53. Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA. 1999. Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J Autoimmun 13: 267-282.
54. Roep BO, Atkinson M, von Herrath M. 2004. Satisfaction (not) guaranteed: Re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 4: 989-997.
55. Roep BO, Kleijwegt FS, van Halteren AG, Bonato V, Boggi U, Vendrame F, Marchetti P, Dotta F. 2010. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 159: 338-343.
56. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS. 1997. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40: 564-572.
57. Schloot NC, Meierhoff G, Karlsson Faresjö M, Ott P, Putnam A, Lehmann P, Gottlieb P, Roep BO, Peakman M, Tree T. 2003. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 21: 365-376.
58. Schloot NC, Meierhoff G, Lengyel C, Vándorfi G, Takács J, Pánczél P, Barkai L, Madácsy L, Oroszlán T, Kovács P, et al. 2007. Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: Two prospective, randomized, double-blind phase II trials. Diabetes Metab Res Rev 23: 276-285.
59. Skowera A, Ellis RJ, Varela-Calviño R, Arif S, Huang GC, Van-Krinks C, Zaremba A, Rackham C, Allen JS, Tree TI, et al. 2008. CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 118: 3390-3402.
60. Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E. 2005. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes Care 28: 1068-1076.
61. Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, Armstrong M, Piganelli JD, Barbour G, Bradley B, Crawford F, et al. 2010. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 11: 225-231.
62. Staeva-Vieira T, Peakman M, von Herrath M. 2007. Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 148: 17-31.
63. Steck AK, Johnson K, Barriga KJ, Miao D, Yu L, Hutton JC, Eisenbarth GS, Rewers MJ. 2011. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: Diabetes autoimmunity study in the young. Diabetes Care 34: 1397-1399.
64. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ. 1993. Induction of type I diabetes by interferon-α in transgenic mice. Science 260: 1942-1946.
65. Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M, DiLorenzo TP, Serreze DV. 2006. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 176: 3257-3265.
66. Thrower SL, James L, Hall W, Green KM, Arif S, Allen JS, Van-Krinks C, Lozanoska-Ochser B, Marquesini L, Brown S, et al. 2009. Proinsulin peptide immunotherapy in type 1 diabetes: Report of a first-in-man phase I safety study. Clin Exp Immunol 155: 156-165.
67. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75.
68. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois-Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, et al. 2005. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci 102: 10581-10586.
69. Toma A, Laïka T, Haddouk S, Luce S, Briand JP, Camoin L, Connan F, LambertM, Caillat-Zucman S, Carel JC, et al. 2009. Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes. Diabetes 58: 394-402.
70. Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT, Santamaria P, Tan R. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111: 217-223.
71. Trudeau JD, Chandler T, Soukhatcheva G, Verchere CB, Tan R. 2007. Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 50: 1015-1023.
72. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1. Eur J Immunol 39: 3147-3159.
73. Unger WW, Velthuis J, Abreu JR, Laban S, Quinten E, Kester MG, Reker-HadrupS, Bakker AH, Duinkerken G, Mulder A, et al. 2011. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. J Autoimmun doi: 10. 1016/j. jaut. 2011. 05. 012.
74. van Venrooij WJ, Pruijn GJ. 2000. Citrullination: A small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2: 249-251.
75. + T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 59: 1721-1730.
76. Wegmann DR, Norbury-Glaser M, Daniel D. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 24: 1853-1857.
77. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, EisenbarthGS, Jensen J, Davidson HW, et al. 2007. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci 104: 17040-17045.
78. Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, Walters J, Eisenbarth GS, Davidson HW, Hutton JC. 2008. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 57: 2693-2697.
79. Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, Ziegler AG, Davidson HW, Hutton JC. 2010. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab 95: 4712-4719.
80. Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, GottliebPA, Greenbaum CJ, Herold KC, Marks JB, et al. 2011. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: A randomised double-blind trial. Lancet 378: 319-327.
81. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. 2009. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155: 173-181.